Histologic Staining Techniques: Hematoxylin and Eosin Staining, Special Stains and Their Uses

In histology, staining techniques are essential for differentiating and identifying cellular components under a microscope. They enhance contrast in tissues, allowing for the detailed examination of cell morphology, structure, and function.


Hematoxylin and Eosin Staining


Hematoxylin and eosin (H&E) staining is a widely used technique in medical histology for analyzing tissue sections. Hematoxylin, a nuclear stain, has an affinity for basophilic substances, such as nucleic acids, and stains them purple-blue. Eosin, on the other hand, is eosinophilic and stains cytoplasmic components and extracellular fibers in varying shades of pink and red.


Steps involved in H&E staining:


  1. Tissue fixation
  2. Embedding in paraffin and sectioning
  3. Deparaffinization and hydration
  4. Hematoxylin staining
  5. Differentiation and bluing
  6. Eosin staining
  7. Dehydration, clearing, and mounting


Special Stains and Their Uses


Special stains are used when H&E does not provide enough contrast or specificity. For instance, Masson's trichrome stain is excellent for differentiating between collagen and muscle fibers, highlighted in blue or green, respectively. This method finds its use in studies of connective tissue and muscular pathology.


On the other hand, silver stain is utilized to visualize structures that are otherwise difficult to see, such as reticular fibers, nerve fibers, and fungi, which appear black against a yellow or light brown background. Toluidine blue, a metachromatic dye, can dye acidic tissue components, like mast cell granules, showing a shift in color from blue to purple. These special stains are crucial for identifying specific structures and diagnosing diseases based on microscopic tissue abnormalities.


Common applications of special stains:


  • Connective Tissue: Masson's trichrome stain
  • Neural Tissue: Silver stain
  • Mast Cells: Toluidine blue


October 18, 2025
𝗦𝗶𝗺𝗽𝗹𝗲 𝗦𝘂𝗺𝗺𝗮𝗿𝘆: This study explores how we can improve lab-grown liver cells for medical research and drug testing. The MTMLab team works with induced pluripotent stem cells (iPSCs) - special cells that can be transformed into liver-like cells - because real human liver cells are hard to obtain. However, these lab-grown liver cells don't function as well as mature adult liver cells. The research team discovered that the surface environment where these cells grow is crucial for their development. We created tiny fiber scaffolds made from different materials like collagen, decellularized livers, and chitosan that mimic the natural structure around liver cells. When liver cells were grown on these specially designed nanofibers for three weeks, they displayed higher function compared to cells grown on standard surfaces. Our key finding was that both the material composition and the nanoscale fiber structure were important - stiffer synthetic fibers or softer materials without the appropriate topography or composition prevented proper cell maturation. This research helps create better lab models of human liver tissue that can be used for testing new drugs and studying liver diseases more effectively.
October 7, 2025
Owen Lally Modeling the synergistic effects of alcohol and fats on liver disease via engineered cocultures In Vitro Liver Toxicology Testing of Rat and Dog Hepatocytes to Reduce In Vivo Regulatory Requirements Nathan Shelton Enhancing the Functions and Hepatitis B Virus Infectability of Primary Human Hepatocytes Protein Microarrays to Probe Synergistic Effects of Extracellular Matrix Composition and Stiffness on Liver Macrophages Lesly Villarreal Engineering a 3D Placental Trophoblast Invasion Platform Via Droplet Microfluidics Gas-permeable Plates to Model Synergetic Effects of Oxygen and Endothelial Factors on Liver Zonation Emanuele Spanghero Modeling the Interplay Between Liver and Heart Diseases via a Human Dual-Organ Platform Engineering High Cell Density Beating Cords of Cardiomyocytes and Fibroblasts via Photopatterned Alginate
May 7, 2025
Our latest study addresses a critical challenge in liver tissue engineering: stem cell-derived liver cells (iHeps) typically remain functionally immature, limiting their usefulness for drug testing and disease modeling. Our research team created 3D microtissues using droplet microfluidics technology by: • Encapsulating iHeps in tiny collagen gel droplets (~250 μm diameter) • Coating these structures with various non-parenchymal cells (NPCs) • Testing different combinations and sequences of supporting cells Key findings: 1) Embryonic fibroblasts and liver sinusoidal endothelial cells (LSECs) produced the most mature iHeps compared to other tested cell types 2) Sequential application of cell signals (embryonic fibroblasts first, then LSECs) yielded optimal maturation 3) Specific growth factors like stromal-derived factor-1 alpha were identified as important maturation enhancers 4) Gene expression analysis confirmed that LSEC/iHep microtissues closely resembled adult human liver cells This platform enables researchers to identify critical cellular interactions and molecular signals that drive liver cell maturation, providing valuable insights for developing more physiologically relevant liver models for drug screening and regenerative medicine applications. https://www.sciencedirect.com/science/article/pii/S174270612500193X SIMPLE SUMMARY: Embryonic fibroblasts and liver sinusoidal endothelial cells dramatically improved iHep maturation compared to other cell types tested, producing more functionally mature liver cells. Sequential application proved crucial—adding embryonic fibroblasts first, followed by endothelial cells, yielded optimal maturation. Specific growth factors including stromal-derived factor-1 enhanced this process. This research enables creation of more authentic mini-liver tissues that function like human liver. These improved models support better drug testing, disease research, and regenerative medicine applications.